Tuppy Owens, a sex therapist who works and advocates on behalf of the disabled, will hold an online lecture on…
Ana de Barros, PhD
Ana holds a PhD in immunology from the University of Lisbon and worked as a postdoctoral researcher at Instituto de Medicina Molecular (iMM) in Lisbon, Portugal. Ana was awarded two FCT fellowships and has won the Portuguese Immunology Society Best Paper and Best Poster award in 2009 and 2010, as well as the CESPU International Research Award in 2010. After leaving the lab to pursue a career in science communication, she served as the director of science communication at iMM Lisbon.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Ana de Barros, PhD
Houston Researchers Develop Wearable Biofeedback System to Improve Balance in Parkinson’s Patients
University of Houston researchers are developing what’s called the Smarter Balance System (SBS), a smartphone-based biofeedback…
10 Quotes to Help You When You’re Feeling Down
We know dealing with a condition such as Parkinson’s disease can sometimes feel, both for the patients and the caregivers. You feel like you’re not…
Consuming at least three servings of low-fat dairy per day is enough to increase the risk of developing Parkinson’s disease by…
Difficulty in Diagnosis Greatly Affects Quality of Life of Parkinson’s Patients, Survey Finds
People living with Parkinson’s disease are frustrated with the difficulty in getting an accurate diagnosis, a new Health Union survey…
AFFiRiS’s new Parkinson’s vaccine, AFFITOPE PD03A, triggered a solid immune response against the alpha-Synuclein (aSyn) protein associated with the disease, according to…
Almost half of Americans said in a survey that awareness of Parkinson’s disease has increased in the past year…
NeuroDerm received a green light from the European Medicines Agency (EMA) for the main design…
The U.S. Patent and Trademark Office has granted Finland’s Herantis Pharma a patent covering the use of mesencephalic astrocyte-derived neurotrophic factor…
African-Americans More Likely Than Whites to Receive Parkinson’s Care in Hospital, Study Reports
African-Americans are more likely to receive care for Parkinson’s disease in a hospital emergency room and have more hospital stays…